Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors

European Journal of Neuroscience

Volumn 25, Issue 6, 2007, Pages 1631-1640

  Centonze, Diego ^a,b   Rossi, Silvia ^a,b   De Chiara, Valentina ^a,b   Prosperetti, Chiara ^a,b   Battista, Natalia ^b,c   Bernardi, Giorgio ^a,b   Mercuri, Nicola B ^a,b   Usiello, Alessandro ^d   Maccarrone, Mauro ^b,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Addiction; Dopamine; Electrophysiology; Habit; IPSC

Indexed keywords

4 AMINOBUTYRIC ACID; CANNABINOID 1 RECEPTOR; COCAINE; DEXANABINOL; GLUTAMIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ABSTINENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; DRUG ABUSE; DRUG SENSITIVITY; DRUG USE; ELECTROPHYSIOLOGY; GABAERGIC SYSTEM; MALE; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; REGULATORY MECHANISM; STRIATE CORTEX; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SYNAPSES; TETRAHYDROCANNABINOL;

EID: 34047261276     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05433.x     Document Type: Article

References (63)

1. Acquas, E. & Di Chiara, G. (1994) D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav. Pharmacol., 5, 555-569.
2. Amalric, M. & Koob, G.F. (1993) Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog. Brain Res., 99, 209-226.
3. Ballon, N., Leroy, S., Roy, C., Bourdel, M.C., Charles-Nicolas, A., Krebs, M.O. & Poirier, M.F. (2006) (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J., 6, 126-130.
4. Beltramo, M., de Fonseca, F.R., Navarro, M., Calignano, A., Gorriti, M.A., Grammatikopoulos, G., Sadile, A.G., Giuffrida, A. & Piomelli, D. (2000) Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J. Neurosci., 20, 3401-3407.
5. Berke, J.D. & Hyman, S.E. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron, 25, 515-532.
6. Borgland, S.L., Malenka, R.C. & Bonci, A. (2004) Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J. Neurosci., 24, 7482-7490.
7. Breivogel, C.S., Griffin, G., Di Marzo, V. & Martin, B.R. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155-163.
8. Carlson, G., Wang, Y. & Alger, B.E. (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nature Neurosci., 5, 723-724.
9. Carrier, E.J., Patel, S. & Hillard, C.J. (2005) Endocannabinoids in neuroimmunology and stress. Curr. Drug Targets CNS Neurol. Disord., 4, 657-665.
10. Centonze, D., Battista, N., Rossi, S., Mercuri, N.B., Finazzi-Agro, A., Bernardi, G., Calabresi, P. & Maccarrone, M. (2004) A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission. Neuropsychopharmacology, 29, 1488-1497.
11. Centonze, D., Costa, C., Rossi, S., Prosperetti, C., Pisani, A., Usiello, A., Bernardi, G., Mercuri, N.B. & Calabresi, P. (2006) Chronic cocaine prevents depotentiation at corticostriatal synapses. Biol. Psychiatry, 60, 436-443.
12. Centonze, D., Picconi, B., Baunez, C., Borrelli, E., Pisani, A., Bernardi, G. & Calabresi, P. (2002) Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology, 26, 164-175.
13. Centonze, D., Rossi, S., Prosperetti, C., Tscherter, A., Bernardi, G., Maccarrone, M. & Calabresi, P. (2005) Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol. Psychiatry, 57, 1583-1589.
14. Chaperon, F., Soubrie, P., Puech, A.J. & Thiebot, M.H. (1998) Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology, 135, 324-332.
15. Chen, N., Appell, M., Berfield, J.L. & Reith, M.E. (2003) Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur. J. Pharmacol., 478, 89-95.
16. Cossu, G., Ledent, C., Fattore, L., Imperato, A., Bohme, G.A., Parmentier, M. & Fratta, W. (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain. Res., 118, 61-65.
17. De Marchi, N., De Petrocellis, L., Orlando, P., Daniele, F., Fezza, F. & Di Marzo, V. (2003) Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis., 2, 5.
18. De Vries, T.J. & Schoffelmeer, A.N. (2005) Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol. Sci., 26, 420-426.
19. De Vries, T.J., Shaham, Y., Homberg, J.R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L.J. & Schoffelmeer, A.N. (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nature Med., 7, 1151-1154.
20. Emrich, H.M., Leweke, F.M. & Schneider, U. (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol. Biochem. Behav., 56, 803-807.
21. Everitt, B.J. & Wolf, M.E. (2002) Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci., 22, 3312-3320.
22. Fourgeaud, L., Mato, S., Bouchet, D., Hemar, A., Worley, P.F. & Manzoni, O.J. (2004) A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J. Neurosci., 24, 6939-6945.
23. Gerdeman, G. & Lovinger, D.M. (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol., 85, 468-471.
24. Gerdeman, G.L., Partridge, J.G., Lupica, C.R. & Lovinger, D.M. (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. TINS, 26, 184-192.
25. Gerdeman, G.L., Ronesi, J. & Lovinger, D.M. (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nature Neurosci., 5, 446-451.
26. Giuffrida, A., Leweke, F.M., Gerth, C.W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkotter, J. & Piomelli, D. (2004) Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology, 29, 2108-2114.
27. Giuffrida, A., Parsons, L.H., Kerr, T.M., Rodriguez de Fonseca, F., Navarro, M. & Piomelli, D. (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neurosci., 2, 358-363.
28. Govaerts, S.J., Hermans, E. & Lambert, D.M. (2004) Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Eur. J. Pharm. Sci., 23, 233-243.
29. Griffin, G., Atkinson, P.J., Showalter, V.M., Martin, B.R. & Abood, M.E. (1998) Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5′-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther., 285, 553-560.
30. Gubellini, P., Picconi, B., Bari, M., Battista, N., Calabresi, P., Centonze, D., Bernardi, G., Finazzi-Agro, A. & Maccarrone, M. (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci., 22, 6900-6907.
31. Hohmann, A.G. & Herkenham, M. (2000) Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse, 37, 71-80.
32. Houchi, H., Babovic, D., Pierrefiche, O., Ledent, C., Daoust, M. & Naassila, M. (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology, 30, 339-349.
33. Huang, C.C., Lo, S.W. & Hsu, K.S. (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol., 532, 731-748.
34. Huang, Y.C., Wang, S.J., Chiou, L.C. & Gean, P.W. (2003) Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J. Neurosci., 23, 10311-10320.
35. Iversen, L. (2003) Cannabis and the brain. Brain, 126, 1252-1270.
36. Kelly, P.H., Seviour, P.W. & Iversen, S.D. (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res., 94, 507-522.
37. Kita, H. (1996) Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparations. Neuroscience, 70, 925-940.
38. Koos, T. & Tepper, J.M. (1999) Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nature Neurosci., 2, 467-472.
39. Le Foll, B. & Goldberg, S.R. (2005) Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J. Pharmacol. Exp. Ther., 312, 875-883.
40. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W. & Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404.
41. Lesscher, H.M., Hoogveld, E., Burbach, J.P., Van Ree, J.M. & Gerrits, M.A. (2005) Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitization. Eur. Neuropsychopharmacol., 15, 31-37.
42. Maccarrone, M., Gubellini, P., Bari, M., Picconi, B., Battista, N., Centonze, D., Bernardi, G., Finazzi-Agrò, A. & Calabresi, P. (2003) Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. J. Neurochem., 85, 1018-1025.
43. Maldonado, R. & Rodriguez de Fonseca, F. (2002) Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci., 22, 3326-3331.
44. Maldonado, R., Valverde, O. & Berrendero, F. (2006) Involvement of the endocannabinoid system in drug addiction. TINS, 29, 225-232.
45. Manabe, T., Wyllie, D.J., Perkel, D.J. & Nicoll, R.A. (1993) Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J. Neurophysiol., 70, 1451-1459.
46. Martin, M., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2000) Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur. J. Neurosci., 12, 4038-4046.
47. Nestler, E.J. (2002) From neurobiology to treatment: progress against addiction. Nature Neurosci., 5, 1076-1079.
48. Nisenbaum, E.S. & Berger, T.W. (1992) Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs. I. In vivo analysis. Neuroscience, 48, 561-578.
49. Parolaro, D., Vigano, D. & Rubino, T. (2005) Endocannabinoids and drug dependence. Curr. Drug Targets CNS Neurol. Disord., 4, 643-655.
50. Pertwee, R.G. & Ross, R.A. (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids, 66, 101-121.
51. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M.A. & Calabresi, P. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neurosci., 6, 501-506.
52. Piomelli, D. (2003) The molecular logic of endocannabinoid signalling. Nature Rev. Neurosci., 4, 873-884.
53. Plenz, D. & Kitai, S.T. (1998) Up and down states in striatal medium spiny neurons simultaneously recorded with spontaneous activity in fast-spiking interneurons studied in cortex-striatum-substantia nigra organotypic cultures. J. Neurosci., 18, 266-283.
54. Schulz, P.E., Cook, P. & Johnston, D. (1994) Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J. Neurosci., 14, 5325-5337.
55. Soria, G., Mendizabal, V., Tourino, C., Robledo, P., Ledent, C., Parmentier, M., Maldonado, R. & Valverde, O. (2005) Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology, 30, 1670-1680.
56. Spano, M.S., Fattore, L., Cossu, G., Deiana, S., Fadda, P. & Fratta, W. (2004) CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br. J. Pharmacol., 143, 343-350.
57. Szabo, B., Dorner, L., Pfreundtner, C., Norenberg, W. & Starke, K. (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience, 85, 395-403.
58. Tanda, G., Munzar, P. & Goldberg, S.R. (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature Neurosci., 3, 1073-1074.
59. Thomas, M.J., Beurrier, C., Bonci, A. & Malenka, R.C. (2001) Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nature Neurosci., 4, 1217-1223.
60. Tunstall, M.J., Oorschot, D.E., Kean, A. & Wickens, J.R. (2002) Inhibitory interactions between spiny projection neurons in the rat striatum. J. Neurophysiol., 88, 1263-1269.
61. Tzschentke, T.M. (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol., 56, 613-672.
62. Ungless, M.A., Whistler, J.L., Malenka, R.C. & Bonci, A. (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature, 411, 583-587.
63. Volkow, N.D., Wang, G.J., Telang, F., Fowler, J.S., Logan, J., Childress, A.R., Jayne, M., Ma, Y. & Wong, C. (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci., 26, 6583-6588.